Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal Written By sheeba farhat27 April 2026 12:50 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited and Organon & Co. has announced that they have entered into a definitive agreement under which...
No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars 'ABSUN' Written By Susmita Roy25 April 2026 5:57 PM ISTMumbai: In a significant ruling on trademark infringement in the pharmaceutical sector, the Bombay High Court has granted relief to Sun Pharmaceutical...
Sun Pharma Submits Binding USD 13 Billion Bid for Organon, Deal May Be India's Largest Pharma Acquisition: Report Written By Parthika Patel24 April 2026 1:00 PM ISTNew Delhi: Sun Pharmaceutical Industries has emerged as the frontrunner in the race to acquire US-based Organon & Co. after submitting a binding...
Bombay HC Grants Relief to Sun Pharma in RACIRAFT Row, Flags Risk of Confusion with ESIRAFT Written By Susmita Roy14 April 2026 2:00 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark disputes, the Bombay High Court has allowed an appeal filed by Sun Pharmaceutical...
Indian Pharma Market Grows 10.1% to Rs 20,012 Cr in March: Report Written By Susmita Roy12 April 2026 11:30 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) registered a value growth of 10.1% in March 2026, reaching Rs 20,012 crore, according to the latest...
Sun Pharma Plans USD 12 Billion Organon Acquisition, Prepares Binding Bid: Report Written By Parthika Patel10 April 2026 9:46 PM ISTMumbai: Sun Pharmaceutical Industries is preparing to submit a binding offer of around USD 12 billion to acquire Organon & Co., in what could...
Bombay HC Grants Relief to Sun Pharma, Restrains Use of PANTOZED Over Similarity with PANTOCID Written By Susmita Roy6 April 2026 9:32 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark disputes, the Bombay High Court in Sun Pharma Laboratories Limited vs. Zawadi...
Sun Pharma Names Former PwC India COO Satyavati Berera as Independent Director Written By Parthika Patel6 April 2026 8:51 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited has approved the appointment of Satyavati Berera as an Independent Director on its Board for a term...
Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX Written By Susmita Roy3 April 2026 3:23 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark infringement, the Delhi High Court in the case of Sun Pharma Laboratories Limited vs...
Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances Written By Parthika Patel29 March 2026 11:30 AM ISTNew Delhi: Sun Pharmaceutical Industries Limited has announced that it will present 14 scientific abstracts highlighting advances in alopecia areata,...
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer Studies Written By Parthika Patel28 March 2026 8:37 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary...
Sun Pharma's ILUMYA Gets USFDA Review Nod for Psoriatic Arthritis Indication Written By Parthika Patel17 March 2026 11:45 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited has announced that the US Food and Drug Administration (USFDA) has accepted for review its...
